NCT00208312
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
- Locations
-
- Multiple study locations (see Central Contact); CV Therapeutics, Inc. Palo Alto, California, United States
Clinical trial condition
Explore clinical trials studying Coronary Artery Disease. Study availability and eligibility vary by location and protocol.
NCT00208312
NCT00233714
NCT01010724
NCT01008345
NCT00731237
NCT00533039
NCT00984776
NCT00456950
NCT00982358
NCT00232765